,,ii  #aaith ,,congress  #ast ,session  
,s4 #cbeh  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,november #bj1 
#bjbe,ms4 ,duckworth 7for herself1 ,mr4 
,hoeven1 ,mr4 ,durbin1 and ,mrs4 ,britt7
 introduced the following bill2 which   
was read twice and referred to the      
,committee on ,commerce1 ,science1 and  
,transportation  ,a ,,bill  ,to require 
the ,administrator of the ,federal      
,aviation ,administration to publish the
 list of medications that the           
,administrator has compiled for purposes
 of the medical certification of airmen 
and air traffic control specialists1 and
 for other purposes4  #a4 ,short title  
,this ,act may be cited as the ,aviation
 ,medication ,transparency ,act of      
#bjbe4  #b4 ,aviation medication        
transparency2 list of approved          
medications  7a7 ,purpose ,the purpose  
of this ,act is to ensure that aviation 
stakeholders1 including airmen1 air     
traffic control specialists1 and        
individuals training to become airmen or

 air traffic control specialists1 who   
are applicants for medical certification
 are informed1 in a user-friendly and   
accessible manner1 of the medications   
they may be safely prescribed4  7b7 ,in 
general ,not later than #a year after   
the date of enactment of this ,act1 the 
,administrator of the ,federal ,aviation
 ,administration 7in this section       
referred to as the ,administrator7 shall
 publish and maintain on a publicly     
available website of the ,federal       
,aviation ,administration 7in this      
section referred to as the ,,faa7 a list
 of medications that the ,administrator1
 as of the date of publication1 has--   
7#a7 determined may be safely prescribed
 to an applicant for medical            
certification to treat certain medical  
conditions2 and  7#b7 approved for      
purposes of the issuance of a medical   
certification to an airman or air       
traffic control specialist4  7c7        
,requirements ,to ensure medical        
appropriateness1 user-friendliness1 and 

appropriate dissemination1 the list     
required under subsection 7b7 shall--   
7#a7 be drafted in consultation with--  
7,a7 the ,aeromedical ,innovation and   
,modernization ,working ,group          
7established under section #daa7;a7 of  
the ,,faa ,reauthorization ,act of #bjbd
 7#di ,u4,s4,c4 #ddgjc note77 7in this  
section referred to as the ,working     
,group72  7,b7 institutions of higher   
education that are accredited by the    
,aviation ,accreditation ,board         
,international2  7,c7 the certified     
exclusive bargaining representatives of 
air traffic controllers of the ,,faa    
certified under section #gaaa of title  
#e1 ,united ,states ,code2  7,d7        
organizations representing certified    
collective bargaining representative of 
airline pilots2 and  7,e7 any other     
stakeholder determined relevant by the  
,working ,group2  7#b7 cover all        
medications approved by the             
,administrator1 including prescription  
medications and over-the-counter        

medications2  7#c7 be drafted in a      
user-friendly and accessible manner and 
provided to airmen1 air traffic control 
specialists1 and individuals training to
 become airmen or air traffic control   
specialists at the time when any such   
individual first seeks a medical        
certification2  7#d7 if applicable1     
indicate the minimum and average period 
of time an airman or air traffic control
 specialist is required to have limited 
or no duties to stabilize on an approved
 medication2  7#e7 include the list of  
medications that the ,administrator has 
designated as ,do ,not ,issue2  7#f7    
include information for doctors or      
medical providers to contact the ,,faa  
regarding questions related to such     
list1 including through a new or        
existing mechanism that is accessible to
 such doctors and medical providers2    
7#g7 include any additional information 
that the ,administrator determines is   
appropriate to provide with respect to  
what conditions a certain medication may

 or may not be used to treat1 as well as
 any information to explain why a       
medication is allowed or prohibited by  
the ,,faa2 and  7#h7 include any other  
information or clarification that the   
,administrator determines appropriate4  
7d7 ,annual update ,not later than #a   
year after the date of publication of   
the list required under subsection 7b71 
and annually thereafter1 the            
,administrator shall update such list1  
as appropriate4